Bird Flu :: NIAID DNA vaccine for H5N1 avian influenza enters human trial

The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.

Flu :: No shortage of flu vaccines in UK

The UK Government has rejected claims that millions of elderly and infirm people are being put at risk of contracting potentially life-threatening flu because of problems distributing the vaccine.

Do NOT follow this link or you will be banned from the site!